Spesolimab: First Approval

被引：65

作者：

Blair, Hannah A. ^{[1
]}

机构：

[1] Springer Nat, Private Bag 65901, Auckland 0754, New Zealand

来源：

DRUGS | 2022年 / 82卷 / 17期

关键词：

D O I：

10.1007/s40265-022-01801-4

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Spesolimab (spesolimab-sbzo; SPEVIGO (R)) is an interleukin (IL)-36 receptor antagonist being developed by Boehringer Ingelheim for the treatment of various immune-mediated disorders. In September 2022, spesolimab was approved in the USA for the treatment of generalized pustular psoriasis (GPP) flares in adults. This article summarizes the milestones in the development of spesolimab leading to this first approval for GPP flares.

引用

页码：1681 / 1686

页数：6

共 17 条

[1] Trial of Spesolimab for Generalized Pustular Psoriasis [J].

Bachelez, H. ;

Choon, S-E ;

Marrakchi, S. ;

Burden, A. D. ;

Tsai, T-F ;

Morita, A. ;

Navarini, A. A. ;

Zheng, M. ;

Xu, J. ;

Turki, H. ;

Anadkat, M. J. ;

Rajeswari, S. ;

Hua, H. ;

Vulcu, S. D. ;

Hall, D. ;

Tetzlaff, K. ;

Thoma, C. ;

Lebwohl, M. G. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (26) :2431-2440

[2] Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis [J].

Bachelez, Herve ;

Choon, Siew-Eng ;

Marrakchi, Slaheddine ;

Burden, A. David ;

Tsai, Tsen-Fang ;

Morita, Akimichi ;

Turki, Hamida ;

Hall, David B. ;

Shear, Michael ;

Baum, Patrick ;

Padula, Steven J. ;

Thoma, Christian .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (10) :981-983

[3] Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis [J].

Baum, Patrick ;

Visvanathan, Sudha ;

Garcet, Sandra ;

Roy, Janine ;

Schmid, Ramona ;

Bossert, Sebastian ;

Lang, Benjamin ;

Bachelez, Herve ;

Bissonnette, Robert ;

Thoma, Christian ;

Krueger, James G. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (04) :1402-1412

[4] IL-1RL2 and Its Ligands Contribute to the Cytokine Network in Psoriasis [J].

Blumberg, Hal ;

Dinh, Huyen ;

Dean, Charles, Jr. ;

Trueblood, Esther S. ;

Bailey, Keith ;

Shows, Donna ;

Bhagavathula, Narasimharao ;

Aslam, Muhammad Nadeem ;

Varani, James ;

Towne, Jennifer E. ;

Sims, John E. .

JOURNAL OF IMMUNOLOGY, 2010, 185 (07) :4354-4362

[5]

Boehringer Ingelheim, 2022, 1 EVER TRE AIMED ALL

[6]

Boehringer Ingelheim, 2021, US FDA GRANTS PRI RE

[7]

Boehringer Ingelheim Pharmaceuticals, 2022, FDA APPR 1 TRE OPT G

[8]

Boehringer Ingelheim Pharmaceuticals, 2022, SPEVIGO SPES SBZ INJ

[9] Clinical Course and Characteristics of Generalized Pustular Psoriasis [J].

Choon, Siew Eng ;

Navarini, Alexander A. ;

Pinter, Andreas .

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (SUPPL 1) :21-29

[10] IL-36 in chronic inflammation and fibrosis - bridging the gap? [J].

Elias, Michael ;

Zhao, Shuai ;

Le, Hongnga T. ;

Wang, Jie ;

Neurath, Markus F. ;

Neufert, Clemens ;

Fiocchi, Claudio ;

Rieder, Florian .

JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (02)

← 1 2 →